{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T13:18:32Z","timestamp":1788095912816,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,2]],"date-time":"2027-01-02T00:00:00Z","timestamp":1798848000000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH092797"],"award-info":[{"award-number":["MH092797"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["NS061025"],"award-info":[{"award-number":["NS061025"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["NS075527"],"award-info":[{"award-number":["NS075527"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["NS134586"],"award-info":[{"award-number":["NS134586"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["NS103988"],"award-info":[{"award-number":["NS103988"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["NS124789"],"award-info":[{"award-number":["NS124789"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018866","name":"Paula and Rodger Riney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007268","name":"Washington University in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006309","name":"American Parkinson Disease Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.nucmedbio.2025.109599","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T22:43:12Z","timestamp":1766356992000},"page":"109599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["PET evaluation of cholinergic system differences in progressive supranuclear palsy and age-matched controls using [18F]VAT"],"prefix":"10.1016","volume":"152-153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-8785","authenticated-orcid":false,"given":"Ying-Hwey","family":"Nai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Tanenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Kumar","family":"Soda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Moerlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3263-8917","authenticated-orcid":false,"given":"Joel S.","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0325-835X","authenticated-orcid":false,"given":"Zhude","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109599_bb0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira T","year":"2016","journal-title":"CN"},{"key":"10.1016\/j.nucmedbio.2025.109599_bb0010","series-title":"Behavioral pharmacology of the cholinergic system","first-page":"1","article-title":"A review of the cholinergic system and therapeutic approaches to treat brain disorders","author":"Bertrand","year":"2020"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109599_bb0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/brain\/awh391","article-title":"Cholinergic systems in progressive supranuclear palsy","volume":"128","author":"Warren","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nucmedbio.2025.109599_bb0020","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1038\/s41380-025-02985-3","article-title":"Cholinergic tone abnormalities and relationships with smoking severity in human cigarette smokers: exploratory positron emission tomography study using [18F]VAT","volume":"30","author":"Moeller","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"15","key":"10.1016\/j.nucmedbio.2025.109599_bb0025","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1016\/j.bmc.2015.05.058","article-title":"Synthesis and biological characterization of a promising F-18 PET tracer for vesicular acetylcholine transporter","volume":"23","author":"Tu","year":"2015","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109599_bb0030","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/jnc.14291","article-title":"Kinetic modeling of [18F]VAT, a novel radioligand for positron emission tomography imaging vesicular acetylcholine transporter in non-human primate brain","volume":"144","author":"Jin","year":"2018","journal-title":"J Neurochem"},{"key":"10.1016\/j.nucmedbio.2025.109599_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174556","article-title":"In vitro characterization of [3H]VAT in cells, animal and human brain tissues for vesicular acetylcholine transporter","volume":"911","author":"Liang","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109599_bb0040","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2967\/jnumed.123.266860","article-title":"PET quantification of [18F]VAT in human brain and its test\u2013retest reproducibility and age dependence","volume":"65","author":"O\u2019Donnell","year":"2024","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.nucmedbio.2025.109599_bb0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1098-2396(199811)30:3<263::AID-SYN4>3.0.CO;2-9","article-title":"[18F]Fluoroethoxy-Benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses","volume":"30","author":"Mulholland","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.nucmedbio.2025.109599_bb0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13550-015-0149-4","article-title":"Radiation dosimetry of [18F]VAT in nonhuman primates","volume":"5","author":"Karimi","year":"2015","journal-title":"EJNMMI Res"},{"issue":"3","key":"10.1016\/j.nucmedbio.2025.109599_bb0055","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2967\/jnumed.113.124792","article-title":"In vivo imaging of human cholinergic nerve terminals with (\u2212)-5- [18F]-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses","volume":"55","author":"Petrou","year":"2014","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.nucmedbio.2025.109599_bb0060","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s00702-022-02547-9","article-title":"Differential cholinergic systems\u2019 changes in progressive supranuclear palsy versus Parkinson\u2019s disease: an exploratory analysis","volume":"129","author":"Kanel","year":"2022","journal-title":"J Neural Transm"},{"issue":"7","key":"10.1016\/j.nucmedbio.2025.109599_bb0065","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1212\/WNL.58.7.1013","article-title":"Cholinergic vesicular transporters in progressive supranuclear palsy","volume":"58","author":"Suzuki","year":"2002","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109599_bb0070","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ana.410180503","article-title":"Dopaminergic and cholinergic lesions in progressive supranuclear palsy","volume":"18","author":"Ruberg","year":"1985","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109599_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115249","article-title":"A central role for acetylcholine in entorhinal cortex function and dysfunction with age in humans and mice","volume":"44","author":"Ananth","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.nucmedbio.2025.109599_bb0080","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109599_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.nucmedbio.2025.109599_bb0090","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.nucmedbio.2025.109599_bb0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.apradiso.2015.09.010","article-title":"Automated production of [18F]VAT suitable for clinical PET study of vesicular acetylcholine transporter","volume":"107","author":"Yue","year":"2016","journal-title":"Appl Radiat Isot"},{"issue":"09","key":"10.1016\/j.nucmedbio.2025.109599_bb0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5414\/NP300608","article-title":"White matter pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases","volume":"32","author":"Armstrong","year":"2013","journal-title":"NP"},{"issue":"supplement 2","key":"10.1016\/j.nucmedbio.2025.109599_bb0105","first-page":"1928","article-title":"Molecular imaging and kinetic analysis toolbox (MIAKAT) - a quantitative software package for the analysis of PET neuroimaging data","volume":"57","author":"Gunn","year":"2016","journal-title":"J Nucl Med"},{"issue":"14","key":"10.1016\/j.nucmedbio.2025.109599_bb0110","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac0d8f","article-title":"Deconvolution-based partial volume correction of PET images with parallel level set regularization","volume":"66","author":"Zhu","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nucmedbio.2025.109599_bb0115","series-title":"Version 1.1.0.0","article-title":"Shapiro-Wilk and Shapiro-Francia normality tests","author":"BenSa\u00efda","year":"2024"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109599_bb0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/1531-8249(199907)46:1<62::AID-ANA10>3.0.CO;2-P","article-title":"Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson\u2019s disease and progressive supranuclear palsy","volume":"46","author":"Shinotoh","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nucmedbio.2025.109599_bb0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.04.014","article-title":"Progressive supranuclear palsy: advances in diagnosis and management","volume":"73","author":"Coughlin","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109599_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","article-title":"Progressive supranuclear palsy: pathology and genetics","volume":"17","author":"Dickson","year":"2007","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109599_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00401-002-0621-x","article-title":"Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration","volume":"105","author":"Kasashima","year":"2003","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.nucmedbio.2025.109599_bb0140","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mds.28901","article-title":"Brainstem biomarkers of clinical variant and pathology in progressive supranuclear palsy","volume":"37","author":"Grijalva","year":"2022","journal-title":"Mov Disord"},{"key":"10.1016\/j.nucmedbio.2025.109599_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuroimage.2014.11.058","article-title":"Partial volume correction in quantitative amyloid imaging","volume":"107","author":"Su","year":"2015","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.nucmedbio.2025.109599_bb0150","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","article-title":"Quantification of amyloid PET for future clinical use: a state-of-the-art review","volume":"49","author":"Pemberton","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109599_bb0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/JAD-180749","article-title":"A comparison of partial volume correction techniques for measuring change in serial amyloid PET SUVR","volume":"67","author":"Schwarz","year":"2019","journal-title":"J Alzheimers Dis"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125006080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125006080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:59:18Z","timestamp":1773968358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805125006080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"alternative-id":["S0969805125006080"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109599","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET evaluation of cholinergic system differences in progressive supranuclear palsy and age-matched controls using [18F]VAT","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109599"}}